Healthy Living Europe
SEE OTHER BRANDS

Keeping up with healthcare and wellness news from Europe

Healthy Living Europe: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthy Living Europe.

Press releases published on April 24, 2025

Tenaya Therapeutics Presents Interim Data from RIDGE™ Natural History and Seroprevalence Study of Adults with PKP2-associated ARVC at Heart Rhythm 2025

Tenaya Therapeutics Presents Interim Data from RIDGE™ Natural History and Seroprevalence Study of Adults with PKP2-associated ARVC at Heart Rhythm 2025

RIDGE is Largest Natural History Study Conducted with More Than 175 Participants Enrolled to Date with Arrhythmogenic Right Ventricular Cardiomyopathy Due to Mutations in the PKP2 Gene Patients Experience High Burden of Arrhythmias and Severe Disease …

Faraday Pharmaceuticals to Host Satellite Symposium at SCAI 2025 on Exploring New Frontiers in Reducing Ischemia-Reperfusion Injury

Faraday Pharmaceuticals to Host Satellite Symposium at SCAI 2025 on Exploring New Frontiers in Reducing Ischemia-Reperfusion Injury

SEATTLE, April 24, 2025 (GLOBE NEWSWIRE) -- Faraday Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company focused on preventing heart failure by reducing myocardial damage in acute ST-elevation myocardial infarction (STEMI) through the …

HealthPRO Canada and the CAN Health Network Join Forces  to Accelerate Procurement of Made-in-Canada Healthcare Innovations

HealthPRO Canada and the CAN Health Network Join Forces to Accelerate Procurement of Made-in-Canada Healthcare Innovations

Oakville, ON, April 24, 2025 (GLOBE NEWSWIRE) -- HealthPRO Canada, the country’s national group contracting provider for healthcare, is proud to announce a strategic partnership with the CAN Health Network (CAN Health) to accelerate the adoption and …

Blood Works Book Now an International Bestseller

Blood Works Book Now an International Bestseller

Milestone Confirmed by World’s Largest Bookseller and Global Distributor; All Proceeds Support Multilingual Access for Broader Health Equity LONDON, UNITED KINGDOM, April 24, 2025 /⁨EINPresswire.com⁩/ -- Blood Works: An Owner’s Guide, the collaborative …

Imprivata Names Joel Burleson-Davis as Chief Technology Officer

Imprivata Names Joel Burleson-Davis as Chief Technology Officer

WALTHAM, Mass., April 24, 2025 (GLOBE NEWSWIRE) -- Imprivata, the digital identity company for life- and mission-critical industries, today announced the appointment of Joel Burleson-Davis to Chief Technology Officer (CTO). Serving most recently as SVP of …

Healing with Data: Transforming Pediatric Care at Leading Maternal and Children’s Hospital Sant Joan de Déu

Healing with Data: Transforming Pediatric Care at Leading Maternal and Children’s Hospital Sant Joan de Déu

Leading Spanish hospital Relies on Denodo Platform for Real-time patient data monitoring and AI-driven analytics, updating data every 30 seconds PALO ALTO, Calif., April 24, 2025 (GLOBE NEWSWIRE) -- Denodo, a leader in data management, announced that …

Dig In! Moley Leads the Charge for Global Action Days

Dig In! Moley Leads the Charge for Global Action Days

London, April 24, 2025 (GLOBE NEWSWIRE) -- Get ready to stomp, soak, drum and dance — because Global Action Days has officially begun, and it’s all happening beneath our feet! Kicking off on Earth Day and continuing for two action-packed weeks, the …

Global Neuroprosthetics Market Expanding Rapidly at a CAGR of ~13% by 2032 Amid Surge in Demand for Advanced Neurological Treatments | DelveInsight

Global Neuroprosthetics Market Expanding Rapidly at a CAGR of ~13% by 2032 Amid Surge in Demand for Advanced Neurological Treatments | DelveInsight

New York, USA, April 24, 2025 (GLOBE NEWSWIRE) -- Global Neuroprosthetics Market Expanding Rapidly at a CAGR of ~13% by 2032 Amid Surge in Demand for Advanced Neurological Treatments | DelveInsight The neuroprosthetics market is experiencing significant …

Sarcopenia Clinical Trial Pipeline Appears Robust With 18+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight

Sarcopenia Clinical Trial Pipeline Appears Robust With 18+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight

New York, USA, April 24, 2025 (GLOBE NEWSWIRE) -- Sarcopenia Clinical Trial Pipeline Appears Robust With 18+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight The sarcopenia market remains largely untapped, with significant …

Huer Foods teams up with BC Women’s Health Foundation to raise funds for infant MRI machine

Huer Foods teams up with BC Women’s Health Foundation to raise funds for infant MRI machine

LANGLEY, British Columbia, April 24, 2025 (GLOBE NEWSWIRE) -- This summer, British Columbians can give back to an important local cause while enjoying a delectable candy treat! Huer Foods—a local candy brand based in BC’s Lower Mainland—has launched a …

Advanced Animal Care Spurs Growth in Veterinary Orthopedic Market: Forecast to Reach USD 956.92 Million by 2034

Advanced Animal Care Spurs Growth in Veterinary Orthopedic Market: Forecast to Reach USD 956.92 Million by 2034

The veterinary orthopedic market is projected to grow steadily from 2024 to 2034, driven by rising demand for advanced treatments and veterinary care services. NEWARK, DE, UNITED STATES, April 24, 2025 /⁨EINPresswire.com⁩/ -- In the contemporary age of …

Global Dental Plaster Market to Reach USD 251.2 Million by 2034, Driven by Steady Demand in Dentistry | FMI

Global Dental Plaster Market to Reach USD 251.2 Million by 2034, Driven by Steady Demand in Dentistry | FMI

The Dental Plaster Market Outlook from 2024 to 2034 highlights trends, growth, and projections for the industry over the next decade. NEWARK, DE, UNITED STATES, April 24, 2025 /⁨EINPresswire.com⁩/ -- The global dental plaster market is projected to …

Guerbet: Q1 2025 revenue

Guerbet: Q1 2025 revenue

Q1 2025 revenue Quarterly activity Revenue: €180.1m, down 7.1% at CER1 and on a like-for-like basis2 As expected, a first quarter marked by a persistent impact on France and a penalizing base effect Declining momentum in Diagnostic Imaging (-8.7% at CER …

GUERBET:  Chiffre d’affaires du 1er trimestre 2025

GUERBET: Chiffre d’affaires du 1er trimestre 2025

Chiffre d’affaires du 1er trimestre 2025 Activité trimestrielle Chiffre d’affaires : 180,1 M€, en repli de 7,1% à TCC1 et périmètre comparable2 Comme anticipé, un premier trimestre marqué par un impact France persistant et un effet de base pénalisant Une …

Koelis annonce un partenariat avec Bot Image™ lors du congrès de l’AUA 2025

Koelis annonce un partenariat avec Bot Image™ lors du congrès de l’AUA 2025

GRENOBLE, France et PRINCETON, New Jersey, 24 avr. 2025 (GLOBE NEWSWIRE) -- Koelis, SAS (« Koelis » ou la « Société », www.koelis.com), société leader et innovante dans le domaine du traitement des maladies de la prostate, a annoncé ce jour un nouveau …

Best Dental Implants in Seattle Done by Dr. Javadi

Best Dental Implants in Seattle Done by Dr. Javadi

​SEATTLE, April 24, 2025 (GLOBE NEWSWIRE) -- Top Seattle periodontist and dental implant surgeon Dr. Ellie Javadi of Orchid Periodontics …

Sharps Technology Announces Reverse Stock Split

Sharps Technology Announces Reverse Stock Split

NEW YORK, April 24, 2025 (GLOBE NEWSWIRE) -- Sharps Technology, Inc. (NASDAQ: “STSS” and “STSSW”) ("Sharps"), an innovative medical device and pharmaceutical packaging company offering patented, best-in-class smart-safety syringe products to the healthcare …

Alkeus Pharmaceuticals Announces Presentations of Gildeuretinol Data During the Research in Vision and Ophthalmology (ARVO) 2025 Annual Meeting May 4-8, 2025

Alkeus Pharmaceuticals Announces Presentations of Gildeuretinol Data During the Research in Vision and Ophthalmology (ARVO) 2025 Annual Meeting May 4-8, 2025

CAMBRIDGE, Mass., April 24, 2025 (GLOBE NEWSWIRE) -- Alkeus Pharmaceuticals, Inc., a biopharmaceutical company dedicated to preserving the sight of individuals impacted by retinal diseases, today announced that results from its clinical studies of …

OBI Pharma kündigt Posterpräsentationen auf der AACR-Jahrestagung 2025 zu den Antikörper-Wirkstoff-Konjugaten (AWK) OBI-992 und OBI-902, den ADC-Enabling-Technologien GlycOBI® und ThiOBI®, dem Prodrug OBI-3424 und der Globo-H-Forschung (GH-Forschung) a…

OBI Pharma kündigt Posterpräsentationen auf der AACR-Jahrestagung 2025 zu den Antikörper-Wirkstoff-Konjugaten (AWK) OBI-992 und OBI-902, den ADC-Enabling-Technologien GlycOBI® und ThiOBI®, dem Prodrug OBI-3424 und der Globo-H-Forschung (GH-Forschung) a…

TAIPEH, Taiwan, April 24, 2025 (GLOBE NEWSWIRE) -- OBI Pharma, Inc. (TPEx: 4174. TWO), hat heute nichtklinische Daten zu OBI-902 bekannt gegeben, einem potenziell in seiner Klasse führenden Anti-TROP2-AWK, das mithilfe der firmeneigenen GlycOBI®- …

OBI Pharma annonce l’exposition d’affiches au congrès annuel de l’AACR 2025 concernant les conjugués anticorps-médicaments (CAM) OBI-992 et OBI-902, les technologies habilitantes relatives aux CAM GlycOBI® et ThiOBI®, le promédicament OBI-3424 et la sc…

OBI Pharma annonce l’exposition d’affiches au congrès annuel de l’AACR 2025 concernant les conjugués anticorps-médicaments (CAM) OBI-992 et OBI-902, les technologies habilitantes relatives aux CAM GlycOBI® et ThiOBI®, le promédicament OBI-3424 et la sc…

TAIPEI, Taïwan, 24 avr. 2025 (GLOBE NEWSWIRE) -- OBI Pharma, Inc. (TPEx : 4174. TWO) a communiqué aujourd’hui des données non cliniques sur OBI-902, un CAM anti-TROP2 potentiellement le meilleur de sa catégorie, développé à l’aide de la nouvelle génération …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service